Post-void residual (PVR) volume and urinary retention assessments in a randomized, double-blind, Phase IIIb trial of mirabegron add-on treatment in incontinent overactive bladder (OAB) patients with an inadequate response to 4-week solifenacin monotherapy (BESIDE)
作者
Marcus J. Drake,Scott MacDiarmid,С Х Аль-Шукри,Jack Barkin,Aino Fianu-Jonasson,P. Grise,Sender Herschorn,Moses Huang,Matthias Stölzel,Claire Hemsted,Emad Siddiqui